1. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD;Erkinjuntti;Int. J. Clin. Pract., Suppl.,2001
2. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl);Maelicke;Int. J. Clin. Pract., Suppl.,2001
3. The prevalence of VaD in Europe: facts and fragments from 1980–1990 studies. EURODEM—Prevalence Research Group;Rocca;Ann. Neurol.,1991
4. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts;Lobo;Neurology,2000
5. Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?;Winblad;Int. J. Geriatr. Psychiatry,2001